Skip to main content

Day: August 27, 2025

Pasinex Announces Q2 2025 Financial Results and Provides Corporate Update

TORONTO, Aug. 27, 2025 (GLOBE NEWSWIRE) — Pasinex Resources Limited (CSE: PSE) (FSE: PNX) (“Pasinex” or the “Company”) today announced financial results for the second quarter ended June 30, 2025. The financial statements, management’s discussion and analysis (MD&A), and related certifications are available on SEDAR+. Highlights                                   Three Months Ended       Six Months Ended              June 30,       June 30,            2025     2024     2025     2024    Financial:                      Share of net equity gain from joint venture   $ 18,633   $ 309,802   $ 61,413   $ 943,280      Consolidated net (loss) income   $ (282,935 ) $ (296,550 ) $ (1,171,412 ) $ (10,778 )    Basic and diluted (net) income per share   $ (0.002 ) $ (0.002 ) $ (0.008 ) $ (0.000 )    Net...

Continue reading

Apellis Pharmaceuticals to Participate in Upcoming Investor Conferences

WALTHAM, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that management will participate in webcast fireside chats at the following investor conferences: Wells Fargo Healthcare Conference Date/Time: Wednesday, September 3, 2025 at 8:45 a.m. ET Cantor Global Healthcare Conference Date/Time: Thursday, September 4, 2025 at 8:35 a.m. ET Baird Global Healthcare ConferenceDate/Time: Tuesday, September 9, 2025 at 10:15 a.m. ET The live conference webcasts will be posted on the “Events and Presentations” page of the “Investors and Media” section of the company’s website. A replay of the webcasts will be available for approximately 30 days following the event. About ApellisApellis Pharmaceuticals, Inc. is a global biopharmaceutical company leading the way in complement science to develop...

Continue reading

Voyageur Mineral Explorers Corp. and Evolve Strategic Element Royalties Ltd. Enter into Definitive Agreement to Complete Reverse Take-Over

Not for distribution to United States newswire services or for release publication, distribution or dissemination, directly or indirectly, in whole or in part, in or into the United States. TORONTO, Aug. 27, 2025 (GLOBE NEWSWIRE) — Voyageur Mineral Explorers Corp. (CSE: VOY) (“Voyageur” or the “Company”) and Evolve Strategic Element Royalties Inc. (“Evolve”) are pleased to announce that the parties have entered into a definitive business combination agreement dated August 26, 2025 (the “Definitive Agreement”), whereby Voyageur will acquire all of the issued and outstanding common shares of Evolve by way of a statutory three-cornered amalgamation under the Business Corporations Act (British Columbia). Upon completion of the proposed business combination (the “Proposed Transaction”), Voyageur (as it exists upon completion of the...

Continue reading

Photronics Reports Third Quarter Fiscal 2025 Financial Results

BROOKFIELD, Conn., Aug. 27, 2025 (GLOBE NEWSWIRE) — Photronics, Inc. (NASDAQ:PLAB), a worldwide leader in photomask technologies and solutions, today reported financial results for its third quarter of fiscal year 2025 ended August 3, 2025. Commenting on the third-quarter performance, Chairman and CEO George Macricostas said, “Photronics delivered very good results in our fiscal third quarter with revenue, profitability and EPS ahead of expectations. Looking ahead, we remain focused on operational efficiency to maintain our excellent standard of maximizing customer cycle times. We will further accelerate internal investment efforts to enhance geographic revenue diversification and position the company for sustained revenue and earnings growth.” Third Quarter Fiscal 2025 ResultsRevenue was $210.4 million, down 0.3% year-over-year...

Continue reading

Minovia Therapeutics Announces $350,000 Grant from Countdown for a Cure Foundation to Develop Mitochondria Blood-Based Biomarkers

HAIFA, Israel, Aug. 27, 2025 (GLOBE NEWSWIRE) — Minovia Therapeutics Ltd. (“Minovia” or the “Company”), a clinical-stage biotechnology company developing novel therapies to treat mitochondrial diseases and combat age-related decline, announces that it has been chosen to receive a $350,000 grant from Countdown for a Cure for a research proposal related to the development of novel mitochondrial blood-based biomarkers. Minovia Chief Scientific Officer Dr. Noa Sher, commented, “We are grateful to the Countdown for a Cure Foundation, whose funds are expected to be instrumental in our advancing development of blood-based functional mitochondrial biomarkers. These biomarkers will enable identification of patients who may benefit from our mitochondrial augmentation technology, or MAT, proprietary platform, as well as patient follow-up...

Continue reading

Ventyx Biosciences to Participate in Three Upcoming Investor Conferences

SAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) — Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”, “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oral therapies for patients with autoimmune, inflammatory, and neurodegenerative diseases, today announced that Company executives will participate in the following upcoming investor conferences:2025 Wells Fargo Healthcare ConferenceLocation: Boston, MADate: Friday, September 5, 2025Time: 11:00-11:35 AM EDTMorgan Stanley 23rd Annual Global Healthcare ConferenceLocation: New York, NYDate: Monday, September 8, 2025H.C. Wainwright 27th Annual Global Investment ConferenceLocation: New York, NYDate: Monday, September 8, 2025A webcast of the Wells Fargo presentation will be available in the Investors and News section of the Ventyx website at www.ventyxbio.com....

Continue reading

Shentel Brings Fiber-to-the-Home Internet to Radford, VA

100% Fiber-Optic Network with Speeds up to 5GbpsTruck InteriorOur hardworking techs heading out for the day in Radford, VA.EDINBURG, Va., Aug. 27, 2025 (GLOBE NEWSWIRE) — Shenandoah Telecommunications Company (“Shentel”) (Nasdaq: SHEN), a leading provider of broadband services, is currently upgrading its network in Radford, Virginia, with 100% fiber-to-the-home internet service. Shentel Fiber will bring symmetrical, multi-gig internet speeds to both residential and business customers, and construction is expected to be completed by the end of the year. “We are pleased with the investment Shentel is making in the City of Radford and the overall upgrade in broadband service reliability, availability, and speed,” said Radford Mayor David Horton. Shentel’s fiber-to-the-home technology, supported by its 17,700-mile regional...

Continue reading

Pet Valu Locks in Lower Prices on Over 100 Pet Products

Canadian Specialty Pet Retailer Expands its Commitment to Offering Devoted Pet Lovers Increased ValueMARKHAM, Ontario, Aug. 27, 2025 (GLOBE NEWSWIRE) — Devoted pet lovers can now save more on their pet’s everyday needs. Starting today, Pet Valu, Canada’s leading specialty retailer of pet food and pet-related supplies, has introduced new lower prices across more than 100 popular items including food, toys, treats, training pads and crates. The new lower prices, which pet parents across Canada can benefit from every day, is the latest step Pet Valu has taken to provide quality pet products at great value. “Since early 2024, we have lowered prices across over 1,000 popular pet products, including our industry-leading Fresh4Life® proprietary branded cat litter last fall, and our line-up of Performatrin Prime® premium dog and cat...

Continue reading

Invivyd to Participate in Upcoming Investor Conferences

WALTHAM, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) — Invivyd, Inc. (Nasdaq: IVVD) today announced that it will present at the following investor conferences: Cantor Global Healthcare Conference 2025Fireside Chat Date: Wednesday, September 3, 2025Fireside Chat Time: 2:10 PM ETLocation: New York, NY H.C. Wainwright 27th Annual Global Investment ConferenceFireside Chat Date: Monday, September 8, 2025Fireside Chat Time: 12:00 PM ETLocation: New York, NY Live webcasts of the fireside chats will be available in the investor section of the company’s website at investors.invivyd.com and will be archived for approximately 30 days following each event. In addition to the fireside chats, the management team will host investor meetings at the conferences. Investors participating in the conferences who are interested in meeting with Invivyd management...

Continue reading

Reliance, Inc. Announces Participation at the Jefferies Industrials Conference

SCOTTSDALE, Ariz., Aug. 27, 2025 (GLOBE NEWSWIRE) — Reliance, Inc. (NYSE: RS) announced today that Karla Lewis, President and Chief Executive Officer, and Stephen Koch, Executive Vice President and Chief Operating Officer, will participate in the Jefferies Industrials Conference on Wednesday, September 3, 2025 in New York City. Reliance is scheduled to present on Wednesday, September 3rd at 3:30 p.m. ET. The presentation will be webcast live over the Internet, hosted on the Investors section of the Company’s website at investor.reliance.com. In addition to the live webcast, a replay will be available on the Company’s website for 90 days following the event. About Reliance, Inc. Founded in 1939, Reliance, Inc. (NYSE: RS) is a leading global diversified metal solutions provider and the largest metals service center company...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.